# A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects

> **NCT05137600** · PHASE1 · COMPLETED · sponsor: **Antios Therapeutics, Inc** · enrollment: 36 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** ATI-2173
- **DRUG:** Midazolam
- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT05137600
- **Lead sponsor:** Antios Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-28
- **Primary completion:** 2021-12-23
- **Final completion:** 2022-01-23
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05137600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05137600, "A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05137600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*